When a Dose Does Not Deliver: Pen Problems, Decoded

It happens in a second. You press the button, and the counter stops short of zero. Or the clicks you expected never quite arrive. Or you pull the pen away and there is a small wet dot at the skin, and now you are standing in the bathroom doing arithmetic with an unknowable number: how much of that went in?

This article is about those minutes, and about the one that follows them. The good news is that pen instructions are clearer on this situation than most people expect, the pen itself usually reports what happened, and the right next step is not a guess. It is a phone call.

What each kind of pen actually tells you

The two pen families give you different evidence, and knowing which family yours belongs to tells you what to look for.

A multi-dose dial pen, of which Ozempic is the example, has a dose counter you dial up before injecting. On this pen, the counter returning to 0 is the signal that the dose went in. Novo Nordisk's instructions add a timing detail that matters: keep the needle in the skin and count slowly to 6 after the counter reaches 0, because the medicine is still moving during those seconds.

A single-dose pen, such as the Wegovy pen and Lilly's Mounjaro and Zepbound single-dose pens, has no counter at all. It signals with sound and with something visible through its window. Lilly's instructions describe a first click when the injection starts, a second click when it finishes, and the gray plunger visible in the window, with the pen held in place for up to about 10 seconds.

The common thread is that each device was designed to report its own completion, in its own way. That is also why the Instructions for Use leaflet that came with your pen is the only authority for that device: these mechanisms differ by product, and a general article, including this one, can only describe the pattern.

The flow check, and a common misunderstanding

Somewhere along the way, the flow check turned into folklore. People describe it as a ritual to perform before every dose, and it is not one.

Novo Nordisk's instructions say to check the flow only before the first injection with each new Ozempic pen. The procedure is short: dial to the flow check symbol, press and hold until the counter shows 0, and look for a drop at the needle tip. That drop tells you the pen is primed and flowing before the first real dose.

If no drop appears, the instructions say to repeat the sequence up to six more times. If there is still no drop after that, the instruction is equally plain: use a new pen and contact the manufacturer. Notice what the sequence does not include. It does not include improvising, and it does not include injecting anyway to see what happens.

The misunderstanding is understandable, because the flow check looks like a safety step, and safety steps feel like they should be repeated. But it is a new-pen step, done once, and turning it into a before-every-dose habit mostly wastes doses. The before-every-dose habit that the instructions do ask for is smaller: attach a fresh needle, and look at the liquid.

Needles are the first suspect

When nothing comes out of a pen, the needle is the most common culprit. A blocked or bent needle is a common reason a pen fails to deliver, and needles fail more quietly than pens do.

The rule that prevents most of these failures appears on every instruction sheet: needles are single use. A fresh needle for every injection is what the instructions say, and it is not a suggestion aimed at hygiene alone. A needle that has been used once has already been stressed once, and a needle used twice has had opportunities to dull, bend and block. Reusing one to save a few cents is the most expensive false economy in this whole subject.

So if an injection misbehaves and you are reconstructing why, start with the needle before blaming the pen. Was it new? Was it attached straight and fully? Was it removed and reattached at any point? These questions resolve more cases than any other line of investigation, and they cost nothing to answer.

The drop at the skin settles nothing

Now to the wet dot. You pulled the pen away and saw a little liquid at the skin, and the question that follows is natural: did part of my dose end up on the outside?

Here is the honest answer. A little liquid at the skin after an injection cannot be measured by eye, so it cannot settle the question. A trace that looks like a lost dose may be a residue from the needle tip, and what looks like nothing may still have been something. The eye is simply not an instrument for this measurement, on any pen, in either direction.

What can settle the question is the pen's own report. On a dial pen, the evidence is the counter: if the dose counter did not return to 0, the full dose was not delivered, and that is the fact that matters, regardless of what the skin looked like. On a single-dose pen, the evidence is the click sequence and the plunger in the window. When the pen's report is clean, the liquid at the skin is a cosmetic observation. When the pen's report is incomplete, the liquid at the skin is beside the point.

GLP 1 Tracker AppLog the dose you took, and put what happened in the note. Your next appointment starts with facts instead of a half-remembered morning. Get the app

Should you take another? The answer is a phone call

Here is the rule that matters more than every mechanism detail above, stated as plainly as it can be stated: when you are not sure whether a dose went in, do not give yourself another one to make up for it.

Not a half dose, not a top-up, not the rest of what the counter seemed to owe you, and not a second full injection to be safe. There is no version of this where guessing is the right move, because the harm being avoided, an accidental double exposure, is exactly the harm a guess can cause. The question of whether any further dose is appropriate belongs to someone who can weigh it properly.

That someone is your pharmacist, or the manufacturer's support line, and both Novo Nordisk and Lilly run support lines for exactly this call. Have the pen and the carton in front of you when you call, describe what you observed in the order you observed it, and let them decide. This is not a deference ritual. The person on the phone knows the device, knows the failure patterns, and in the case of the manufacturer, made the pen.

It is usually less urgent than it feels in the moment, too. Weekly medicines have published late-dose windows measured in days, which our missed dose guide covers product by product. There is room for a phone call before anything has to be decided, which is the entire point of making one.

Log what actually happened

Whatever the call concludes, the dose entry is where the record belongs. Log the dose you did take: the date, the medication, the site, which is a habit worth keeping anyway since GLP-1 Injection Site Rotation: Why It Matters and How to Track It makes the case that the site is half the story of a comfortable injection.

Then use the note field on that dose entry. A short note does more work than people expect: counter stopped short, called pharmacist, told to wait for next scheduled dose. That one line captures the event, the consultation and the outcome, so the next appointment has the facts instead of a half-remembered morning three weeks ago.

The note is also where a pattern becomes visible. One failed injection is a device event. Three in a quarter, each with a note describing the same counter behavior, is information your pharmacist or prescriber will genuinely use. Writing down what happened, including what the person on the phone said, is how a confusing two minutes turns into a usable fact.